The most lucrative of the schemes prosecutors described Tuesday centered on solicitation of $240 million in medically unnecessary cancer genetic tests. In other news, a Texas woman is charged with defrauding the VA of $640,000.
from Kaiser Health News https://ift.tt/2mZ8vky
0 comments:
Post a Comment